InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-37.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Cherevka Holli, Chief Executive Officer. Director active across 1 company, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been published. Activity tracked since 21 May 2021. The latest transaction was disclosed on 1 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
47,200 shares@ US$0.5714.1% of flowCommon StockSEC:0001415889-22-000258
47,200 shares@ US$0.5711.43% mcap14.1% of flowCommon StockSEC:0001415889-22-000258:0
41,980 shares@ US$1.6428.55% mcap35.2% of flowCommon StockSEC:0001415889-21-005018:0
41,980 shares@ US$1.6435.2% of flowCommon StockSEC:0001415889-21-005018
500,000 shares0Common StockSEC:0001415889-21-004868:0
500,000 shares0Common StockSEC:0001415889-21-004868
2,603 shares@ US$0.510.52% mcap0.6% of flowCommon StockSEC:0001415889-21-002667:0
2,603 shares@ US$0.510.6% of flowCommon StockSEC:0001415889-21-002667
8 of 8 declarations
About Cherevka Holli
Holli Cherevka is the Chief Operating Officer and President at Ampio Pharmaceuticals, Inc. She leads the company's operations, ensuring that strategic objectives are met. Holli brings extensive experience in the pharmaceutical sector, contributing to innovation and growth at Ampio. Her leadership is essential for the company's future.
